GetTopicDetailResponse(id=39f732319a, topicName=Bavituximab, introduction=Bavituximab, content=null, image=null, comments=1, allHits=350, url=https://h5.medsci.cn/topic?id=3231, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=93335, tagList=[TagDto(tagId=93335, tagName=Bavituximab)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780286, encodeId=7c9d1e8028692, content=<a href='/topic/show?id=39f732319a' target=_blank style='color:#2F92EE;'>#Bavituximab#</a>, objectTitle=Oncologie宣布與Merck進(jìn)行臨床試驗(yàn)合作，評估Bavituximab與PD-1單抗KEYTRUDA聯(lián)合治療晚期胃癌或胃食管癌, objectType=article, longId=177568, objectId=24091e7568e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24091e7568e4, replyNumber=0, likeNumber=78, createdTime=2019-08-29, rootId=0, userName=xugc, userId=1e1c493, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24091e7568e4, moduleTitle=Oncologie宣布與Merck進(jìn)行臨床試驗(yàn)合作，評估Bavituximab與PD-1單抗KEYTRUDA聯(lián)合治療晚期胃癌或胃食管癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=24091e7568e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
